Next Article in Journal
Genetic and Structural Analyses of Coronaviruses: Insights into SARS-CoV-2 and Beyond
Previous Article in Journal
Back to the Future—A 50-Year Dive into Embryo Implantation Research: Cell Biological Paradox, Epithelial Cell Polarity, and EMT
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 16
Issue 2
10.3390/biom16020294
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Biomolecules 2023, 13(3), 438.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438

by
Nikki Lyn Esnardo Upfold
1,
Pavlo Petakh
2,3,
Aleksandr Kamyshnyi
3 and
Valentyn Oksenych
1,4,*
1
Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway
2
Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine
3
Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine
4
Institute of Clinical Medicine (Klinmed), University of Oslo, 0318 Oslo, Norway
*
Author to whom correspondence should be addressed.
Biomolecules 2026, 16(2), 294; https://doi.org/10.3390/biom16020294
Submission received: 5 February 2026 / Accepted: 11 February 2026 / Published: 13 February 2026
Versions Notes
The journal retracts the article titled “Tyrosine Kinase Inhibitors Target B Lymphocytes” [1], cited above.
Following publication, concerns were raised about the ownership of the data presented within this article and the accuracy of the authorship contributions.
In accordance with standard journal procedure, the Editorial Office and Editorial Board conducted an investigation with input from the relevant institutions and governing bodies, which concluded that appropriate permission to publish the data had not been obtained prior to publication, and that retroactive permission could not be obtained. The authors fully cooperated with the Editorial Office investigation; however, the Editorial Office and Editorial Board concurred with the presented findings and recommendation from the institution. As the disputed data have a substantial impact on the findings and results of the publication the Editorial Board has decided to retract this article as per MDPI’s retraction policy.
This retraction was approved by the Editor-in-Chief of Biomolecules.
The authors have been informed of this retraction and have indicated their disagreement with this decision.

Reference

  1. Upfold, N.L.E.; Petakh, P.; Kamyshnyi, A.; Oksenych, V. RETRACTED: Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Upfold, N.L.E.; Petakh, P.; Kamyshnyi, A.; Oksenych, V. RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438. Biomolecules 2026, 16, 294. https://doi.org/10.3390/biom16020294

AMA Style

Upfold NLE, Petakh P, Kamyshnyi A, Oksenych V. RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438. Biomolecules. 2026; 16(2):294. https://doi.org/10.3390/biom16020294

Chicago/Turabian Style

Upfold, Nikki Lyn Esnardo, Pavlo Petakh, Aleksandr Kamyshnyi, and Valentyn Oksenych. 2026. "RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438" Biomolecules 16, no. 2: 294. https://doi.org/10.3390/biom16020294

APA Style

Upfold, N. L. E., Petakh, P., Kamyshnyi, A., & Oksenych, V. (2026). RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 2023, 13, 438. Biomolecules, 16(2), 294. https://doi.org/10.3390/biom16020294

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop